|
1
|
Porcu P, Haverkos B, Brem E, Vallurupalli A, Feldman T, Alpdogan O, Brammer J, Bryan L, Barta S, Schriefer A, Obrzut S, Shen H, Rochford R, Baiocchi R, Casper C, Gutheil J, Melink T, Kearns C, Burner D, McRae R, Daniels P, Warren M, Woody J, Royston I, Faller D. A PHASE 1B/2 STUDY OF ORAL NANATINOSTAT (N) AND VALGANCICLOVIR (VG) IN SUBJECTS WITH EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED LYMPHOMAS. Hematol Oncol 2019. [DOI: 10.1002/hon.148_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- P. Porcu
- Medical Oncology and Hematopoietic Stem Cell Transplantation; Thomas Jefferson University; Philadelphia United States
| | - B. Haverkos
- Hematology; University of Colorado School of Medicine; Aurora United States
| | - E. Brem
- Hematology/Oncology; University of California Irvine; Orange United States
| | - A. Vallurupalli
- Hematologic Malignancies and Cellular Therapeutics; University of Kansas Medical Center; Kansas City United States
| | - T. Feldman
- Hematology & Oncology; John Theurer Cancer Center; Hackensack United States
| | - O. Alpdogan
- Medical Oncology and Hematopoietic Stem Cell Transplantation; Thomas Jefferson University; Philadelphia United States
| | - J. Brammer
- Hematology; Ohio State University; Columbus United States
| | - L.J. Bryan
- Oncology; Augusta University; Augusta United States
| | - S. Barta
- Hematology; University of Pennsylvania; Philadelphia United States
| | - A. Schriefer
- Oncologia; Clinica Cehon; Canela Salvador Brazil
| | - S. Obrzut
- Radiology; University of California San Diego; La Jolla United States
| | - H. Shen
- Microbiology; University of Pennsylvania; Philadelphia United States
| | - R. Rochford
- Immunology & Microbiology; University of Colorado; Aurora United States
| | - R. Baiocchi
- Hematology; Ohio State University; Columbus United States
| | - C. Casper
- Research; Infectious Disease Research Institute; Seattle United States
| | - J. Gutheil
- SciQuus Oncology Inc; La Jolla United States
| | - T. Melink
- SciQuus Oncology Inc; La Jolla United States
| | - C. Kearns
- SciQuus Oncology Inc; La Jolla United States
| | - D. Burner
- SciQuus Oncology Inc; La Jolla United States
| | - R. McRae
- Viracta Therapeutics; Cardiff United States
| | - P. Daniels
- Viracta Therapeutics; Cardiff United States
| | | | - J. Woody
- Latterell Venture Partners; San Francisco United States
| | - I. Royston
- Viracta Therapeutics; Cardiff United States
| | - D. Faller
- Hematology & Medical Oncology; Boston University School of Medicine; Boston United States
| |
Collapse
|